• Mashup Score: 0
    Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness: A Matched Cohort Study: Annals of Internal Medicine: Vol 0, No 0 - 6 month(s) ago

    Background: Atrial fibrillation (AF) is often detected for the first time in patients who are hospitalized for another reason. Long-term risks for AF recurrence in these patients are unclear. Objective: To estimate risk for AF recurrence in patients with new-onset AF during a hospitalization for noncardiac surgery or medical illness compared with a matched population without AF. Design: Matched cohort study. (ClinicalTrials.gov: NCT03221777) Setting: Three academic hospitals in Hamilton, Ontario, Canada. Participants: The study enrolled patients hospitalized for noncardiac surgery or medical illness who had transient new-onset AF. For each participant, an age- and sex-matched control participant with no history of AF from the same hospital ward was recruited. All participants left the hospital in sinus rhythm. Measurements: 14-day electrocardiographic (ECG) monitor at 1 and 6 months and telephone assessment at 1, 6, and 12 months. The primary outcome was AF lasting at least 30 seconds

    Source: www.acpjournals.org
    Categories: General Medicine Journals and Societies, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AnnalsofIM
      AnnalsofIM

      Patients with new-onset atrial fibrillation during hospitalization face a surprising 1 in 3 risk of AF recurrence within 1 year, according to a new study. Findings highlight importance of vigilant monitoring and care. https://t.co/s5sSDLUzaE #AtrialFibrillation #HeartHealth #afib https://t.co/AtoxjIX14U

  • Mashup Score: 0
    Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness: A Matched Cohort Study: Annals of Internal Medicine: Vol 0, No 0 - 7 month(s) ago

    Background: Atrial fibrillation (AF) is often detected for the first time in patients who are hospitalized for another reason. Long-term risks for AF recurrence in these patients are unclear. Objective: To estimate risk for AF recurrence in patients with new-onset AF during a hospitalization for noncardiac surgery or medical illness compared with a matched population without AF. Design: Matched cohort study. (ClinicalTrials.gov: NCT03221777) Setting: Three academic hospitals in Hamilton, Ontario, Canada. Participants: The study enrolled patients hospitalized for noncardiac surgery or medical illness who had transient new-onset AF. For each participant, an age- and sex-matched control participant with no history of AF from the same hospital ward was recruited. All participants left the hospital in sinus rhythm. Measurements: 14-day electrocardiographic (ECG) monitor at 1 and 6 months and telephone assessment at 1, 6, and 12 months. The primary outcome was AF lasting at least 30 seconds

    Source: www.acpjournals.org
    Categories: General Medicine Journals and Societies, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AnnalsofIM
      AnnalsofIM

      Patients with new-onset atrial fibrillation during hospitalization face a surprising 1 in 3 risk of AF recurrence within 1 year, according to a new study. Findings highlight importance of vigilant monitoring and care. https://t.co/s5sSDLUzaE #AtrialFibrillation #HeartHealth https://t.co/6BZlmvOqiV

  • Mashup Score: 0
    Boston Scientific launches LUX-Dx II+ Insertable Cardiac Monitor System - 7 month(s) ago

    October 3, 2023 — Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation insertable monitor for long-term monitoring of arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope.  The system is designed with dual-stage algorithms that detect and then verify potential arrhythmias before an alert is sent to clinicians, thereby providing actionable data for clinical decision-making. Further, the remote programming capabilities of the device allow physicians and care teams to adjust event detection settings and record symptoms without requiring an in-person patient appointment.  The dual-stage algorithms within the LUX-Dx II+ ICM System can be programmed to identify AF, atrial and ventricular tachycardia, bradycardia and rhythm pause episodes. These algorithms, including a new premature ventricular contraction (PVC) burden, allow the device to detect arrhythmias each time established thresholds or

    Source: www.dicardiology.com
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DAICeditor
      DAICeditor

      @DAICeditor @bostonsci Boston Scientific launched the LUX-Dx II+ Insertable #CardiacMonitor System, a next-generation insertable monitor for long-term monitoring of arrhythmias associated with #atrialfibrillation (AF), #cryptogenic #stroke and #syncope: https://t.co/JfsNo6zeVp

  • Mashup Score: 0
    OMRON Academy - 7 month(s) ago

    Medical coursesShort and interactive e-learning courses created by medical experts on cardiovascular and respiratory topicsWebinarsMedical experts in the field provide you with the latest insights on medical topics within these webinarsCertificatesSuccessfully complete a free online course, and receive a certificate in your account Hypertension in ChildrenHeart FailureElectrocardiographyRemote…

    Source: academy.omron-healthcare.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of KnowYourPulse
      KnowYourPulse

      Learn more about the importance of early AFIb detection? Join OMRON Academy, an e-learning platform for healthcare professionals https://t.co/dXkHqehsyo #OMRONComplete #hypertension #atrialfibrillation @OmronHealthEU https://t.co/Fk3LQKtX5M

Load More